Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy

The novel ability to quantify drug and tracer concentrations in vivo by optical means leads to the possibility of detecting and quantifying blood brain barrier (BBB) disruption in real-time by monitoring concentrations of chromophores such as Evan’s Blue. In this study, experiments were conducted to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuro-oncology 2011-08, Vol.104 (1), p.11-19
Hauptverfasser: Joshi, Shailendra, Ergin, Aysegul, Wang, Mei, Reif, Roberto, Zhang, Jane, Bruce, Jeffrey N., Bigio, Irving J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 19
container_issue 1
container_start_page 11
container_title Journal of neuro-oncology
container_volume 104
creator Joshi, Shailendra
Ergin, Aysegul
Wang, Mei
Reif, Roberto
Zhang, Jane
Bruce, Jeffrey N.
Bigio, Irving J.
description The novel ability to quantify drug and tracer concentrations in vivo by optical means leads to the possibility of detecting and quantifying blood brain barrier (BBB) disruption in real-time by monitoring concentrations of chromophores such as Evan’s Blue. In this study, experiments were conducted to assess the disruption of the BBB, by intraarterial injection of mannitol, in New Zealand white rabbits. Surgical preparation included: tracheotomy for mechanical ventilation, femoral and selective internal carotid artery (ICA) catheterizations, skull screws for monitoring electrocerebral activity, bilateral placement of laser Doppler probes and a small craniotomy for the placement of a fiber optic probe to determine tissue Evan’s Blue dye concentrations. Evans Blue (6.5 mg/kg) was injected intravenously (IV) just before BBB disruption with intracarotid mannitol (25%, 8 ml/40 s). Brain tissue concentrations of the dye in mannitol-treated and control animals were monitored using the method of optical pharmacokinetics (OP) during the subsequent 60 min. Hemodynamic parameters, heart rate, blood pressure, and EKG remained stable throughout the experiments in both the control and the mannitol-treated group. Brain tissue concentrations of Evan’s Blue and the brain:plasma Evan’s Blue partition coefficient progressively increased during the period of observation. A wide variation in brain tissue Evan’s Blue concentrations was observed in the mannitol group. The experiments demonstrate the feasibility of measuring tissue concentrations of Evan’s Blue without invading the brain parenchyma, and in real-time. The data suggest that there are significant variations in the degree and duration of BBB disruption induced with intraarterial mannitol. The ability to optically monitor the BBB disruption in real-time could provide a feedback control for hypertonic disruption and/or facilitate dosage control for chemotherapeutic drugs that require such disruption.
doi_str_mv 10.1007/s11060-010-0466-4
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4013427</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2418366641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-47e7b39c795480744a1825da9376ef0b5f44274ad0e30b9160bb083fecf75c6f3</originalsourceid><addsrcrecordid>eNp1kUuLFTEQhYMoznX0B7iR4MZVa1UnnXS7EIbBx8CAGwV3IUmn52boTtokLdx_by53HB_gIgSqvnNSlUPIc4TXCCDfZEQQ0ADWw4Vo-AOyw06yRjLJHpIdoJBNN_BvZ-RJzrcAwCXDx-SsReyY6HFH4lWwMWSfiwuFmjnGkZqkfaBGp-RdoqPPaVuLj7V0oD6UpHUqLnk900WH4Euca5kmbYwv-S31yzp7q4-KTKeYqN27JZa9S3o9PCWPJj1n9-zuPidfP7z_cvmpuf788ery4rqxHUBpuHTSsMHKoeM9SM419m036oFJ4SYw3cR5K7kewTEwAwowBno2OTvJzoqJnZN3J991M4sbrTvOPas1-UWng4raq787we_VTfyhOCCr1tXg1Z1Bit83l4tafLZunnVwcctqqF_PcIC2ki__IW_jlkLdTvU9sq4Xsq8QniCbYs7JTfejIKhjmOoUpqphqmOYilfNiz93uFf8Sq8C7QnItRVuXPr98v9dfwL_wa0I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881358678</pqid></control><display><type>article</type><title>Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Joshi, Shailendra ; Ergin, Aysegul ; Wang, Mei ; Reif, Roberto ; Zhang, Jane ; Bruce, Jeffrey N. ; Bigio, Irving J.</creator><creatorcontrib>Joshi, Shailendra ; Ergin, Aysegul ; Wang, Mei ; Reif, Roberto ; Zhang, Jane ; Bruce, Jeffrey N. ; Bigio, Irving J.</creatorcontrib><description>The novel ability to quantify drug and tracer concentrations in vivo by optical means leads to the possibility of detecting and quantifying blood brain barrier (BBB) disruption in real-time by monitoring concentrations of chromophores such as Evan’s Blue. In this study, experiments were conducted to assess the disruption of the BBB, by intraarterial injection of mannitol, in New Zealand white rabbits. Surgical preparation included: tracheotomy for mechanical ventilation, femoral and selective internal carotid artery (ICA) catheterizations, skull screws for monitoring electrocerebral activity, bilateral placement of laser Doppler probes and a small craniotomy for the placement of a fiber optic probe to determine tissue Evan’s Blue dye concentrations. Evans Blue (6.5 mg/kg) was injected intravenously (IV) just before BBB disruption with intracarotid mannitol (25%, 8 ml/40 s). Brain tissue concentrations of the dye in mannitol-treated and control animals were monitored using the method of optical pharmacokinetics (OP) during the subsequent 60 min. Hemodynamic parameters, heart rate, blood pressure, and EKG remained stable throughout the experiments in both the control and the mannitol-treated group. Brain tissue concentrations of Evan’s Blue and the brain:plasma Evan’s Blue partition coefficient progressively increased during the period of observation. A wide variation in brain tissue Evan’s Blue concentrations was observed in the mannitol group. The experiments demonstrate the feasibility of measuring tissue concentrations of Evan’s Blue without invading the brain parenchyma, and in real-time. The data suggest that there are significant variations in the degree and duration of BBB disruption induced with intraarterial mannitol. The ability to optically monitor the BBB disruption in real-time could provide a feedback control for hypertonic disruption and/or facilitate dosage control for chemotherapeutic drugs that require such disruption.</description><identifier>ISSN: 0167-594X</identifier><identifier>EISSN: 1573-7373</identifier><identifier>DOI: 10.1007/s11060-010-0466-4</identifier><identifier>PMID: 21153681</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Animals ; Blood Pressure - drug effects ; Blood-Brain Barrier - drug effects ; Brain - drug effects ; Brain - metabolism ; Brain Waves - drug effects ; Electroencephalography ; Evans Blue - metabolism ; Heart Rate - drug effects ; Hemodynamics - drug effects ; Hemodynamics - physiology ; Injections, Intra-Arterial - methods ; Laboratory Investigation - Human/Animal Tissue ; Laser-Doppler Flowmetry - methods ; Mannitol - administration &amp; dosage ; Medicine ; Medicine &amp; Public Health ; Neurology ; Oncology ; Rabbits ; Sweetening Agents - administration &amp; dosage ; Time Factors ; Tissue Distribution - drug effects ; Tissue Distribution - physiology</subject><ispartof>Journal of neuro-oncology, 2011-08, Vol.104 (1), p.11-19</ispartof><rights>Springer Science+Business Media, LLC. 2010</rights><rights>Springer Science+Business Media, LLC. 2011</rights><rights>Springer Science+Business Media, LLC. 2010 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-47e7b39c795480744a1825da9376ef0b5f44274ad0e30b9160bb083fecf75c6f3</citedby><cites>FETCH-LOGICAL-c500t-47e7b39c795480744a1825da9376ef0b5f44274ad0e30b9160bb083fecf75c6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11060-010-0466-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11060-010-0466-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21153681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Joshi, Shailendra</creatorcontrib><creatorcontrib>Ergin, Aysegul</creatorcontrib><creatorcontrib>Wang, Mei</creatorcontrib><creatorcontrib>Reif, Roberto</creatorcontrib><creatorcontrib>Zhang, Jane</creatorcontrib><creatorcontrib>Bruce, Jeffrey N.</creatorcontrib><creatorcontrib>Bigio, Irving J.</creatorcontrib><title>Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy</title><title>Journal of neuro-oncology</title><addtitle>J Neurooncol</addtitle><addtitle>J Neurooncol</addtitle><description>The novel ability to quantify drug and tracer concentrations in vivo by optical means leads to the possibility of detecting and quantifying blood brain barrier (BBB) disruption in real-time by monitoring concentrations of chromophores such as Evan’s Blue. In this study, experiments were conducted to assess the disruption of the BBB, by intraarterial injection of mannitol, in New Zealand white rabbits. Surgical preparation included: tracheotomy for mechanical ventilation, femoral and selective internal carotid artery (ICA) catheterizations, skull screws for monitoring electrocerebral activity, bilateral placement of laser Doppler probes and a small craniotomy for the placement of a fiber optic probe to determine tissue Evan’s Blue dye concentrations. Evans Blue (6.5 mg/kg) was injected intravenously (IV) just before BBB disruption with intracarotid mannitol (25%, 8 ml/40 s). Brain tissue concentrations of the dye in mannitol-treated and control animals were monitored using the method of optical pharmacokinetics (OP) during the subsequent 60 min. Hemodynamic parameters, heart rate, blood pressure, and EKG remained stable throughout the experiments in both the control and the mannitol-treated group. Brain tissue concentrations of Evan’s Blue and the brain:plasma Evan’s Blue partition coefficient progressively increased during the period of observation. A wide variation in brain tissue Evan’s Blue concentrations was observed in the mannitol group. The experiments demonstrate the feasibility of measuring tissue concentrations of Evan’s Blue without invading the brain parenchyma, and in real-time. The data suggest that there are significant variations in the degree and duration of BBB disruption induced with intraarterial mannitol. The ability to optically monitor the BBB disruption in real-time could provide a feedback control for hypertonic disruption and/or facilitate dosage control for chemotherapeutic drugs that require such disruption.</description><subject>Animals</subject><subject>Blood Pressure - drug effects</subject><subject>Blood-Brain Barrier - drug effects</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Brain Waves - drug effects</subject><subject>Electroencephalography</subject><subject>Evans Blue - metabolism</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics - drug effects</subject><subject>Hemodynamics - physiology</subject><subject>Injections, Intra-Arterial - methods</subject><subject>Laboratory Investigation - Human/Animal Tissue</subject><subject>Laser-Doppler Flowmetry - methods</subject><subject>Mannitol - administration &amp; dosage</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurology</subject><subject>Oncology</subject><subject>Rabbits</subject><subject>Sweetening Agents - administration &amp; dosage</subject><subject>Time Factors</subject><subject>Tissue Distribution - drug effects</subject><subject>Tissue Distribution - physiology</subject><issn>0167-594X</issn><issn>1573-7373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kUuLFTEQhYMoznX0B7iR4MZVa1UnnXS7EIbBx8CAGwV3IUmn52boTtokLdx_by53HB_gIgSqvnNSlUPIc4TXCCDfZEQQ0ADWw4Vo-AOyw06yRjLJHpIdoJBNN_BvZ-RJzrcAwCXDx-SsReyY6HFH4lWwMWSfiwuFmjnGkZqkfaBGp-RdoqPPaVuLj7V0oD6UpHUqLnk900WH4Euca5kmbYwv-S31yzp7q4-KTKeYqN27JZa9S3o9PCWPJj1n9-zuPidfP7z_cvmpuf788ery4rqxHUBpuHTSsMHKoeM9SM419m036oFJ4SYw3cR5K7kewTEwAwowBno2OTvJzoqJnZN3J991M4sbrTvOPas1-UWng4raq787we_VTfyhOCCr1tXg1Z1Bit83l4tafLZunnVwcctqqF_PcIC2ki__IW_jlkLdTvU9sq4Xsq8QniCbYs7JTfejIKhjmOoUpqphqmOYilfNiz93uFf8Sq8C7QnItRVuXPr98v9dfwL_wa0I</recordid><startdate>20110801</startdate><enddate>20110801</enddate><creator>Joshi, Shailendra</creator><creator>Ergin, Aysegul</creator><creator>Wang, Mei</creator><creator>Reif, Roberto</creator><creator>Zhang, Jane</creator><creator>Bruce, Jeffrey N.</creator><creator>Bigio, Irving J.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20110801</creationdate><title>Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy</title><author>Joshi, Shailendra ; Ergin, Aysegul ; Wang, Mei ; Reif, Roberto ; Zhang, Jane ; Bruce, Jeffrey N. ; Bigio, Irving J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-47e7b39c795480744a1825da9376ef0b5f44274ad0e30b9160bb083fecf75c6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Blood Pressure - drug effects</topic><topic>Blood-Brain Barrier - drug effects</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Brain Waves - drug effects</topic><topic>Electroencephalography</topic><topic>Evans Blue - metabolism</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics - drug effects</topic><topic>Hemodynamics - physiology</topic><topic>Injections, Intra-Arterial - methods</topic><topic>Laboratory Investigation - Human/Animal Tissue</topic><topic>Laser-Doppler Flowmetry - methods</topic><topic>Mannitol - administration &amp; dosage</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurology</topic><topic>Oncology</topic><topic>Rabbits</topic><topic>Sweetening Agents - administration &amp; dosage</topic><topic>Time Factors</topic><topic>Tissue Distribution - drug effects</topic><topic>Tissue Distribution - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joshi, Shailendra</creatorcontrib><creatorcontrib>Ergin, Aysegul</creatorcontrib><creatorcontrib>Wang, Mei</creatorcontrib><creatorcontrib>Reif, Roberto</creatorcontrib><creatorcontrib>Zhang, Jane</creatorcontrib><creatorcontrib>Bruce, Jeffrey N.</creatorcontrib><creatorcontrib>Bigio, Irving J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neuro-oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joshi, Shailendra</au><au>Ergin, Aysegul</au><au>Wang, Mei</au><au>Reif, Roberto</au><au>Zhang, Jane</au><au>Bruce, Jeffrey N.</au><au>Bigio, Irving J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy</atitle><jtitle>Journal of neuro-oncology</jtitle><stitle>J Neurooncol</stitle><addtitle>J Neurooncol</addtitle><date>2011-08-01</date><risdate>2011</risdate><volume>104</volume><issue>1</issue><spage>11</spage><epage>19</epage><pages>11-19</pages><issn>0167-594X</issn><eissn>1573-7373</eissn><abstract>The novel ability to quantify drug and tracer concentrations in vivo by optical means leads to the possibility of detecting and quantifying blood brain barrier (BBB) disruption in real-time by monitoring concentrations of chromophores such as Evan’s Blue. In this study, experiments were conducted to assess the disruption of the BBB, by intraarterial injection of mannitol, in New Zealand white rabbits. Surgical preparation included: tracheotomy for mechanical ventilation, femoral and selective internal carotid artery (ICA) catheterizations, skull screws for monitoring electrocerebral activity, bilateral placement of laser Doppler probes and a small craniotomy for the placement of a fiber optic probe to determine tissue Evan’s Blue dye concentrations. Evans Blue (6.5 mg/kg) was injected intravenously (IV) just before BBB disruption with intracarotid mannitol (25%, 8 ml/40 s). Brain tissue concentrations of the dye in mannitol-treated and control animals were monitored using the method of optical pharmacokinetics (OP) during the subsequent 60 min. Hemodynamic parameters, heart rate, blood pressure, and EKG remained stable throughout the experiments in both the control and the mannitol-treated group. Brain tissue concentrations of Evan’s Blue and the brain:plasma Evan’s Blue partition coefficient progressively increased during the period of observation. A wide variation in brain tissue Evan’s Blue concentrations was observed in the mannitol group. The experiments demonstrate the feasibility of measuring tissue concentrations of Evan’s Blue without invading the brain parenchyma, and in real-time. The data suggest that there are significant variations in the degree and duration of BBB disruption induced with intraarterial mannitol. The ability to optically monitor the BBB disruption in real-time could provide a feedback control for hypertonic disruption and/or facilitate dosage control for chemotherapeutic drugs that require such disruption.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>21153681</pmid><doi>10.1007/s11060-010-0466-4</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0167-594X
ispartof Journal of neuro-oncology, 2011-08, Vol.104 (1), p.11-19
issn 0167-594X
1573-7373
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4013427
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Animals
Blood Pressure - drug effects
Blood-Brain Barrier - drug effects
Brain - drug effects
Brain - metabolism
Brain Waves - drug effects
Electroencephalography
Evans Blue - metabolism
Heart Rate - drug effects
Hemodynamics - drug effects
Hemodynamics - physiology
Injections, Intra-Arterial - methods
Laboratory Investigation - Human/Animal Tissue
Laser-Doppler Flowmetry - methods
Mannitol - administration & dosage
Medicine
Medicine & Public Health
Neurology
Oncology
Rabbits
Sweetening Agents - administration & dosage
Time Factors
Tissue Distribution - drug effects
Tissue Distribution - physiology
title Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A13%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inconsistent%20blood%20brain%20barrier%20disruption%20by%20intraarterial%20mannitol%20in%20rabbits:%20implications%20for%20chemotherapy&rft.jtitle=Journal%20of%20neuro-oncology&rft.au=Joshi,%20Shailendra&rft.date=2011-08-01&rft.volume=104&rft.issue=1&rft.spage=11&rft.epage=19&rft.pages=11-19&rft.issn=0167-594X&rft.eissn=1573-7373&rft_id=info:doi/10.1007/s11060-010-0466-4&rft_dat=%3Cproquest_pubme%3E2418366641%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=881358678&rft_id=info:pmid/21153681&rfr_iscdi=true